HLS Therapeutics Inc's total assets for Q2 2025 were $149.07M, a decrease of -3.17% from the previous quarter. TSE:HLS total liabilities were $82.51M for the fiscal quarter, a -5.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.